FDA Approved: COLUMVI — Original Application (Genentech, Inc.)

View source ↗

Summary

FDA approved Columvi (glofitamab) from Genentech via an original biologics license application. The approval covers use in adults with relapsed or refractory fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Columvi (glofitamab)

Snippet

ORIG AP for COLUMVI (GLOFITAMAB)